Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- Can Pharma Survive DTC Ad Restrictions?
- Can Pharma Survive DTC Ad Restrictions?DTCsPublished on www.brainblogger.comYour Television as you doctor?Often, usually on television, one viewing will often at times see an advertisement for some type of medication- usually one involved in a large market disease state and the commercial is sponsored usually by a big pharmaceutical company for...
- Discussion threads 2008-07-07
Additional Resources
- Can Pharma Survive DTC Ad Restrictions?
- The rise of the modern pharmaceutical industry is closely intertwined with the advent of "direct-to-consumer" advertising -- those ubiquitous TV and magazine ads for antidepressants, sleep aids, erectile-dysfunction drugs and a whole slew of other treatments. In fact, it's hard to imagine how the industry could ever...
- Blog posts 2008-05-20
- FDA NEAR RULING ON DTC DRUG ADS ON TV: GOV'T TO FOLLOW INSIGHTS GLEANED FROM 2 SURVEYS
- The Food & Drug Administration intends to issue final rules for direct-to-consumer prescription drug commercials by the end of summer and revise print DTC ad rules by yearend. The Food & Drug Administration intends to issue final rules for direct-to-consumer prescription drug commercials by the end...
- Research articles 1998-06-29
- Congress eyes DTC ad threat; Ad groups ready to combat curbs they expect to be proposed soon.(direct-to-consumer ad costs and health care cost increases)(Brief Article)
- Two House committees blame direct-to-consumer advertising in part for rising health-care costs and are considering steps to force cutbacks in a category that generates more than $2.5 billion in annual ad spending. Two House committees blame direct-to-consumer advertising in part for rising health-care...
- Research articles 2001-08-27
- GAO report: FDA bureaucracy gums up DTC ad reviews
- A GOVERNMENT Accountability Office report said the FDA has failed to implement an effective system for tracking and prioritizing reviews of DTC ads-and that the gap between reviews of violative ads and the issuance of regulatory letters continues to widen as a result. From 1997-2002, the report said, it took...
- Research articles 2008-06-01
- Insomnia and Antidepressant Sales Give Lie to DTC Myths
- Direct-to-consumer drug advertising has almost no relationship with consumer demand for prescriptions. That is one interpretation of a story in Ad Age showing that scrips for insomnia pills (such as Sanofi-Aventis's Ambien CR) and antidepressants (such as Eli Lilly's Cymbalta) are up, even though advertising in both those categories is...
- Blog posts 2009-03-05
- PhRMA's New Drug Ad Rules Still Lack an Enforcement Mechanism
- PhRMA has published new rules for direct-to-consumer drug advertising. Although the new rules are more strict than the previous ones, they still have one giant hole in them -- enforcement is non existent. Plus, Rep. Henry Waxman D-Calif., just announced that as head of the Committee on Energy and Commerce,...
- Blog posts 2008-12-10
- Pharmed out.(ad spending by pharmaceutical industry)
- With drug marketers trying to kick the ad habit, TV is beginning to experience withdrawal symptoms. At least that's what appears to have happened by the midpoint of 2005, according to estimates released last week by ad tracker Nielsen Monitor-Plus. While overall ad spending by direct-to-consumer...
- Research articles 2005-09-05
- DTC DRUG AD SPENDING CLIMBS 43% IN 1ST HALF.(Statistical Data Included)
- Direct-to-consumer prescription drug advertising in the U.S. climbed 43% in the first half of 1999, vs. a year ago, to $905 million, according to IMS Health. TV remains the top medium, accounting for 59% of all DTC advertising for the first half. DTC spending on TV climbed...
- Research articles 1999-10-18
- Ask Your Doctor If This Ad Is Right for You
- By Arlene Weintraub Does it seem like you hear the phrase "ask your doctor" every time you turn on the TV? There's a reason. Drug companies spend about $5 billion a year in the U.S. on ads imploring people to talk to their physicians if they think a pill they've...
- News items 2009-11-05
- FDA negatives may be tuned out
- Those product negatives that the FDA insists be part of every DTC ad in the name of "fair balance" need not be the great sales killer many marketers think. The more a DTC ad is repeated, says University of California-Berkeley marketing professor Peter Sealey, the more the public is likely...
- Research articles 1999-07-01
- Pfizer expects $35 mil DTC push for Viagra. (direct-to-consumer ad campaign)(Brief Article)
- [NEW YORK] The first pill treatment for impotence, Viagra, received approval late last week and, will appear in an estimated $25 million to $35 million ...[NEW YORK] The first pill treatment for impotence, Viagra, received approval late last week and, will appear in an estimated $25 million...
- Research articles 1998-03-30
- Congress looks at DTC; FDA likes Rocephin ad
- Congressional interest in DTC rising Congressional interest in the effect of DTC advertising on drug prices is likely to grow in this election, two Washington observers told a 2/28 Drug Information Association conference on "Marketing Pharmaceuticals in the New Millennium," although legislation is not likely to be adopted. Bennett, Turner...
- Research articles 2000-04-01
- Millward Brown Launches Defense of Drug Ad Effectiveness
- Research agency Millward Brown has attacked a Harvard Medical School survey which concluded direct-to-consumer prescription drug advertising does not work. Back in September, Harvard published a study that compared U.S. drug commercials for Nasonex, Enbrel and Zelnorm, seen by English and French-speaking Canadian audiences. The results indicated that sales were...
- Blog posts 2008-12-01
- Pfizer, Lilly, Boehring award sizeable ad accounts to Mcgarrybowen, LLNS, JWT
- ADVERTISING ACCOUNTS were awarded in January for two major developmental drugs: Pfizer handed the DTC and professional advertising business for its Phase III insomnia drug Indiplon to Mcgarrybowen and Lyons Lavey Nickel Swift, respectively; while the global DTC account for Lilly and Boehringer-Ingelheim's (B-I) duloxetine for stress-induced urinary incontinence in...
- Research articles 2004-02-01
- Sanofi-Aventis' Ambien CR ads skirt new DTC rules
- WITH JUST MONTHS of patent life left on its original Ambien, Sanofi-Aventis kicked off DTC for Ambien CR zolpidem tartrate last month with a 15secondTV reminder ad, a 60-second spot and a coupon for a free seven-day trial.
- Research articles 2005-12-01
- The TV ad that changed the drug world
- Anyone remember when pharma marketing was limited to doctor-oriented pitches? NPR takes us back to that time, highlighting the brainstorm of Joe Davis, who figured out in 1986 how to advertise the allergy drug Seldane on TV. That was before the law changed to allow drug brands to be mentioned...
- News items 2009-10-14
- FDA GIVES OK FOR CLARITIN TO USE CELEBRITY ENDORSER: DTC DRUG ADS STARRING LUNDEN ARE LATEST STEP INTO MAINSTREAM
- The Food & Drug Adminstration has cleared the first celebrity endorsement for a prescription drug TV ad, the use of former "Good Morning America" host Joan Lunden for Schering-Plough Corp.'s Claritin. The Food & Drug Adminstration has cleared the first celebrity endorsement for a prescription...
- Research articles 1998-07-13
- Editorial: FDA actions benefit DTC.(Viewpoint )(direct-to-consumer drug advertising)(Brief Article)(Editorial)
- Direct-to-consumer drug advertisers should support active Food and Drug Administration regulation of their ads-even when it sometimes hurts, as in the FDA case against Pravachol ads this month. Credible ad regulation is a necessary cost of business i Direct-to-consumer drug advertisers should support active Food and...
- Research articles 2003-08-18
- Congress studies DTC rise; Concern voiced over drug costs; no action taken.(Food and Drug Administration)(Government Activity)(Brief Article)
- Congress' first look at the effect of rapid direct-to-consumer drug ad growth resulted in statements of concern, but no immediate action other than a call for further study. Congress' first look at the effect of rapid direct-to-consumer drug ad growth resulted in statements of...
- Research articles 2001-06-18
- << Previous
- page 1 of 1
- Next >>
